ACE and Alzheimer disease: Moreover, authors found in AD patients moderately strong associations between CSF ACE activity and platelet-derived growth factor beta receptor (sPDGFR), a marker of pericyte damage, and between CSF ACE2 activity and CSF albumin levels, a marker of BBB leakiness (Kehoe et al., 2019).